Escaping the catch 22 of lupus anticoagulant testing

High-risk patients with antiphospholipid syndrome (APS) experience increased risk of thrombosis when treated with direct oral anticoagulant (DOAC) therapy compared with warfarin. It is essential to establish the APS diagnosis to choose therapy and determine treatment duration. It requires testing fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Vinholt, Pernille Just, Just, Søren Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Lupus
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059445/
https://www.ncbi.nlm.nih.gov/pubmed/32144138
http://dx.doi.org/10.1136/rmdopen-2019-001156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059445/
https://www.ncbi.nlm.nih.gov/pubmed/32144138
http://dx.doi.org/10.1136/rmdopen-2019-001156

Ejemplares similares